Open Lending to Attend the Canaccord Genuity 44th Annual Growth Conference
AUSTIN, Texas, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Open Lending Corporation (Nasdaq: LPRO) (“Open Lending” or the “Company”), an industry...
PR News
Laser Photonics and Boston Engineering Announce Partnership To Equip Naval Robotic Crawler With Laser Technology
Contacts Investor Relations Contact: laser@haydenir.com Media Contact: Karla Kizzort Marketing Specialist Laser Photonics Corporation kkizzort@laserphotonics.com Laser Photonics Corporation (LPC) (NASDAQ:...
Kopin Corporation Regains Compliance with Nasdaq Minimum Bid Price Requirement
Contacts For Investor Relations Kopin Corporation Richard Sneider, 508-870-5959 Treasurer and Chief Financial Officer rsneider@kopin.com MZ Contact Brian M. Prenoveau,...
Jasper Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Developments
Enrollment in BEACON and SPOTLIGHT studies progressing faster than expected; enrollment in the 240mg single-dose cohort of the BEACON study...
Jiayin Group Inc. to Release Second Quarter 2024 Unaudited Financial Results on Tuesday, August 27, 2024
SHANGHAI, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform...
JetBlue Announces Pricing of $400 Million Convertible Senior Notes Offering
Contacts JetBlue Investor Relations Tel: +1 718 709 2202 ir@jetblue.com JetBlue Corporate Communications Tel: +1 718 709 3089 corpcomm@jetblue.com JetBlue...
IO Biotech Reports Second Quarter 2024 Financial Results and Provides Business Highlights
NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic...
MiNK Reports Second Quarter 2024 Results and Business Update
NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery,...
Indaptus Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage...
IN8bio Solidifies Position as a Clinical Leader of Gamma-Delta T Cell Therapy in Oncology with 100% of Treated AML Patients in Complete Remission and Receives FDA Guidance for Registrational Trial of INB-100
NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company developing innovative gamma-delta...
Immatics Announces Second Quarter 2024 Financial Results and Business Update
Houston, Texas and Tuebingen, Germany, August 13, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical...
ChipMOS REPORTS SECOND QUARTER 2024 RESULTS
HSINCHU, Aug. 13, 2024 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 andNasdaq: IMOS), an...
ImmunityBio’s ANKTIVA® Now Covered By More Than a Dozen Insurance Plans Representing Over 100 Million Lives Within Months of FDA Approval
ANKTIVA® reaches U.S. commercial and Medicare insurance coverage milestone within three months of FDA approval Global expansion of commercial and...
HYZON ANNOUNCES SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS
Launched 200kW Class 8 Fuel Cell Truck Trial Program with Multiple Large Fleets in July BOLINGBROOK, Ill., Aug. 13, 2024...
Hut 8 Reports Second Quarter 2024 Results
Revenue of $35.2 million and 9,102 self-mined Bitcoin on balance sheet as of quarter endClosed $150 million strategic investment from...
Humacyte Second Quarter 2024 Financial Results and Business Update
-FDA requires additional time to complete its review of ATEV™ (acellular tissue engineered vessel) BLA for the Treatment of Vascular...
H&E Equipment Services Reports Quarterly Cash Dividend
BATON ROUGE, La., Aug. 13, 2024 (GLOBE NEWSWIRE) -- H&E Equipment Services, Inc. (NASDAQ: HEES) announced that its Board of...
Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
Received NMPA approval of avatrombopag maleate tablets for the treatment of CLD-associated thrombocytopenia, expanding rare disease product linesReceived IND approval...
Faraday Future Delivers an Additional FF 91 2.0
Contacts Investors (English): ir@faradayfuture.com Investors (Chinese): cn-ir@faradayfuture.com Media: john.schilling@ff.com Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future”, “FF” or...
Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
~ Achieved Second Quarter 2024 Total Net Revenues of $7.3 Million ~~ Appointed Jeffrey S. Hackman as Chief Executive Officer...
5E Advanced Materials Supports Fastmarkets’ Efforts to Increase Visibility of the Global Boron Market
HESPERIA, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”),...
4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
EMERYVILLE, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic...
Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
Key scientific achievements drive the expansion of the pipeline of molecular glue degraders Performance-based and programme-based payments of in total...
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
REHOVOT, Israel, Aug. 12, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) (the "Company", "Evogene"), a leading computational biology company...
Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14
COPENHAGEN, Denmark, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio...
EHang to Report Second Quarter 2024 Unaudited Financial Results on Thursday, August 22, 2024
GUANGZHOU, China, Aug. 12, 2024 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading...
Nynas Streamlines Complex Communications with Descartes’ Transportation Management Solution
LIER, Belgium and ATLANTA, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting...
Diodes Incorporated to Participate at Upcoming Financial Conferences
Contacts Company Contact: Diodes Incorporated Gurmeet Dhaliwal Director, Investor Relations and Corporate Marketing P: 408-232-9003 E: gurmeet_dhaliwal@diodes.com Investor Relations Contact:...
Dragonfly Energy Powers Highway Transport’s Fleet with Battle Born All-Electric APUs
RENO, Nev., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an...
Dragonfly Energy Powers Highway Transport’s Fleet with Battle Born All-Electric APUs
RENO, Nev., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an...
Citi Trends Sets Date for Second Quarter 2024 Earnings Release and Conference Call
Contacts Tom Filandro ICR, Inc. CitiTrendsIR@icrinc.com Citi Trends, Inc. (NASDAQ: CTRN) today announced plans to release its earnings for the...
CervoMed Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
- Completed enrollment in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with early-stage dementia with Lewy bodies...
Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
-- Highly-experienced hematologist and oncologist with proven track record successfully driving global clinical development of CAR-T cell therapies --BERKELEY, Calif.,...
Coya Therapeutics Provides a Corporate Update and Reports Unaudited Second Quarter 2024 Financial Results
Contacts Investors David Snyder david@coyatherapeutics.com CORE IR Bret Shapiro brets@coreir.com 561-479-8566 Media Kati Waldenburg media@coyatherapeutics.com 212-655-0924 Coya Therapeutics, Inc. (Nasdaq:...
Columbia Banking System Announces $0.36 Per Common Share Dividend
TACOMA, Wash., Aug. 12, 2024 /PRNewswire/ -- Columbia Banking System, Inc. ("Columbia"Nasdaq: COLB), parent company of Umpqua Bank, today announced...
Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update
Company continues to make significant progress towards disrupting the existing cochlear implant industry with its investigational, breakthrough fully implanted Acclaim®...
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024
BOSTON and LONDON, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims...
Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update
– Phase 3 ACTION Study On-Track; First Interim Overall Survival Data Expected Third Quarter 2025 – – ONC206...
Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update
BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...
Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update
FLORHAM PARK, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...